For the year ending 2025-12-31, ACRS has $160,460K in assets. $57,378K in debts. $19,960K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 19,960 | |||
| Short-term marketable securities | 70,791 | |||
| Accounts receivable, prepaid expenses and other current assets | 5,565 | |||
| Total current assets | 96,316 | |||
| Marketable securities | 60,612 | |||
| Property and equipment, net | 761 | |||
| Other assets | 2,771 | |||
| Total assets | 160,460 | |||
| Accounts payable | 13,158 | |||
| Accrued expenses | 8,791 | |||
| Deferred income | 3,943 | |||
| Other current liabilities | 2,753 | |||
| Total current liabilities | 28,645 | |||
| Other liabilities | 1,565 | |||
| Deferred income, net of current portion | 16,168 | |||
| Contingent consideration | 11,000 | |||
| Total liabilities | 57,378 | |||
| Common stock, 0.00001 par value 400,000,000 and 200,000,000 shares authorized at december 31, 2025 and december 31, 2024, respectively 120,499,433 and 107,850,124 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 1 | |||
| Additional paidin capital | 1,070,255 | |||
| Accumulated other comprehensive income | 610 | |||
| Accumulated deficit | -967,784 | |||
| Total stockholders' equity | 103,082 | |||
| Total liabilities and stockholders' equity | 160,460 | |||
Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. (ACRS)